Leprosy Mailing List – February 17th, 2011
Ref.: Infolep choice of new (e-)publications on leprosy
From: Erlings J., Amsterdam , Netherlands
Dear Dr Noto,
Greetings!
Below you will find a selection of new publications on leprosy. Please contact me for full text versions. Do you have publications on leprosy to share? Please let me know!
With kind regards,
Jiske Erlings
Jiske Erlings
INFOLEP Leprosy Information Services
P.O. Box 95005 Ι 1090 HA Amsterdam
Netherlands
Netherlands
Tel.: + 31 20 5950530 Fax: +31 20 6680823
E-mail: infolep(at)leprastichting.nl
E-mail: J.Erlings(at)Leprastichting.NL
Journals |
New issue of Leprosy Review, 2010, issue no.4 Download articles from: http://www.leprahealthinaction.org/lr/Dec10/Lep346-347.pdf |
1: Di Martino Ortiz B, Masi MR, Knopfelmacher O, de Lezcano LB. [Childhood leprosy: Report of a case.]. Dermatology online journal. 2011;17(1):13.
Free full text available from: http://dermatology.cdlib.org/1701/8_vignette/13_10-00171/ortiz.html
2: Forastiero R, Martinuzzo M, De Larrañaga G, Vega-Ostertag M, Pierangeli S. Anti-?(2) glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model. Journal of thrombosis and haemostasis : JTH. 2011.
3: Franco L, de Carvalho GL, Carneiro HM, Pinto SA, de Carvalho RM. [Medial canthus necrosis associated with Hansen's disease: case report.]. Arquivos brasileiros de oftalmologia. 2010;73(6):539-40.
Free full text available from: http://www.scielo.br/pdf/abo/v73n6/v73n6a16.pdf
4: Gertler PJ, Martinez S, Premand P, Rawlings RB, Vermeersch CM. Impact evaluation in practice.
Free full text available from:http://siteresources.worldbank.org/EXTHDOFFICE/Resources/5485726-1283444590513/IEP_001-262_final.pdf
5: Hali F, Benchikhi H, Azzouzi S, Zamiati S, Latifi A, Sbai M. [Familial histoid leprosy.]. Annales de dermatologie et de venereologie. 2011;138(1):42-5.
6: Kai M, Nguyen Phuc NH, Nguyen HA, Pham TH, Nguyen KH, Miyamoto Y, et al. Analysis of drug-resistant strains of mycobacterium leprae in an endemic area of Vietnam. Clin Infect Dis. 2011;52(5):e127-32.
7: Ramien ML, Wong A, Keystone JS. Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept. Clin Infect Dis. 2011;52(5):e133-5.
Free full text available from: http://cid.oxfordjournals.org/content/52/5/e133.full.pdf+html
8: Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, et al. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC infectious diseases. 2011;11(1):26.
Free full text available from: http://www.biomedcentral.com/content/pdf/1471-2334-11-26.pdf
9: Teixeira F, Ribeiro A, Bogas M, Afonso C, Araújo D. [Chronic tophaceous arthropathy and leprosy in the same patient.]. Acta reumatologica portuguesa. 2010;35(5):526-8.
8: Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, et al. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC infectious diseases. 2011;11(1):26.
Free full text available from: http://www.biomedcentral.com/content/pdf/1471-2334-11-26.pdf
9: Teixeira F, Ribeiro A, Bogas M, Afonso C, Araújo D. [Chronic tophaceous arthropathy and leprosy in the same patient.]. Acta reumatologica portuguesa. 2010;35(5):526-8.
10: Wiker HG, Tomazella GG, de Souza GA. A quantitative view on Mycobacterium leprae antigens by proteomics. Journal of proteomics. 2011.
Thesis |
Slim FJ. Functioning with leprosy impairments in The Netherlands: the consequences and diagnosis of foot abnormalities. Amsterdam: University of Amsterdam; 2011.
No comments:
Post a Comment